DICE Therapeutics Inc
DICE
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.27B
Close$
Share Statistics
| Market cap | $2.27 Billion |
|---|---|
| Enterprise Value | $2.21 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.07 |
| Beta | 0 |
| Outstanding Shares | 47,310,035 |
Return
| Return on Equity | -18.70% |
|---|---|
| Return on Assets | -17.63% |
| Return on Invested Capital | -21.51% |
Valuation & Multiples
| P/E Ratio | -22.94 |
|---|---|
| PEG | -38.06 |
| Price to Sales | - |
| Price to Book Ratio | 4.76 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -19.38 |
| Enterprise Value to Net Income | -23 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About DICE Therapeutics Inc
2,021 employees